Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms

Research Policy

Volumn 31, Issue 3, 2002, Pages 381-398

  Ramani, Shyama V ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Biotechnology; India; Pharmaceutical sector; R d strategies

Indexed keywords

EID: 31244437897     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0048-7333(01)00115-9     Document Type: Article

References (35)

1. Acharya, R., 1995. The impact of New Technologies on Economic Growth and Trade: A case Study of Biotechnology. Ph.D. Thesis, University of Masstricht.
2. Ahmad, H., 1988. Technological Development in Drugs and Pharmaceutical Industry in India. Navrang, New Delhi.
3. Arora, A., Gambardella, A., 1990. Complementarity and external linkages: the strategies of large firms in biotechnology. Journal of Industrial Economics 4, 361-379.
4. Basant, R., Fikkert, B., 1996. The effects of R&D, foreign technology purchase, and domestic and international spillovers on productivity in Indian firms. Review of Economics and Statistics, pp. 187-199.
5. Biotech Consortium Ltd., 1994. Directory of Biotechnology Industries and Institutions in India. New Delhi, India.
6. Centre for Monitoring Indian Economy (CMIE), 1996. The Indian Corporate Sector, Bombay.
7. Cockburn, I., Henderson, R., Stern, S., 1999. The diffusion of science driven drug discovery: organizational change in pharmaceutical research. Working paper 7359. National Bureau of Economic Research, 1050 Massachusetts Avenue, Cambridge, MA 02138.
8. Deolalikar, A.B., Evenson, R.E., 1989. Technology production and technology purchase in Indian industry: an econometric analysis. Review of Economics and Statistics, pp. 687-692.
9. Department of Biotechnology, Government of India, 1993. Research Profile of Biotechnology Activities in India. New Delhi, India.
10. Desai, A.V., 1980. The origin and direction of industrial R&D in India. Research Policy 9, 74-96.
11. Desai, A.V., 1988. Technology acquisition and application: interpretations of the Indian experience. In: Lucas, R.E., Papanek, G.F. (Eds.), The Indian economy. Oxford University Press, Oxford.
12. Ernst, Young, L.L.P., 1998. New Directions 98, The 12th Biotechnology Industry Annual Report, CA.
13. Ferrantino, M.J., 1992. Technology expenditures, factor intensity and efficiency in Indian manufacturing. The Review of Economics and Statistics, pp. 689-699.
14. Gambardella, A., 1995. Science and Innovation in the US Pharmaceutical Industry. Cambridge University Press, Cambridge.
15. Grilliches, Z., 1979. Issues in assessing the contribution of research and development to productivity growth. Bell Journal of Economics 10, 92-116.
16. Grilliches, Z., 1995. R&D and productivity. Handbook of the Economics of Innovation and Technological Change. Oxford University Press, UK and Cambridge University Press, USA, Blackwell Scientific Publications, Oxford, pp. 52-89.
17. Henderson, R., Cockburn, I., 1994. Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal 15, 63-84.
18. Katrak, H., 1985. Imported technology, enterprise size and R&D in a newly industrializing country: The Indian experience. Oxford Bulletin of Economics and Statistics 47, 213-229.
19. Katrak, H., 1989. Imported technologies and R&D in a newly industrialising country. Journal of development economics 31, 123-139.
20. Katrak, H., 1994. Imports of technology, enterprise size and R&D-based production in a newly industrializing country: the evidence from Indian enterprises. World Development 22, 1599-1608.
21. Kumar, N., Saqib, M., 1996. Firm size, opportunities for adaptation and in-house R&D activity for developing countries: the case of Indian manufacturing. Research Policy 25, 713-722.
22. Lanjouw, J.O., 1998. The introduction of pharmaceutical patents in Indian: heartless exploitation of the poor and suffering? National Bureau of Economic Research, Working paper 6366.
23. Nath, P., 1993. Firm size and in-house R&D: the Indian experience revisited. The Developing Economies 3, 329-344.
24. Office of Technology Assessment, O.T.A., 1991. Biotechnology in a global economy. US congress office of Technology Assessment, US Government Printing Office, Washington DC.
25. Orsenigo, L., 1989. The Emergence of Biotechnology. Pinter, London.
26. Pisano, G.P., 1991. The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry. Research Policy 20, 237-249.
27. Probert, J., 1994. Japanese Pharmaceutical Firms. Players in the European Market. In: Helmut Schutle (Ed.), The Global Competitiveness of the Asian Firm. St. Martins Press, New York.
28. Ramani, S.V., Venkataramani, M.S., 2001. Rising to the technological challenge: possibilities for integration of biotechnology in the Indian pharmaceutical industry. The International Journal of Biotechnology, 3, no 1/2.
29. Ramani, S.V., Visalakshi, S., 2001. The chicken or the egg problem revisited: the role of resources and incentives in the integration of biotechnology techniques. The International Journal of Biotechnology, in press.
30. Raut, L.R., 1995. R&D spillover and productivity growth: evidence from Indian private firms. Journal of Development Economics 48, 1-23.
31. Redwood, H., 1994. New Horizons in India. Oldwicks Press Limited, Suffolk, England.
32. Sasson, A., 1993. Biotechnologies in Developing Countries, Present and Future, UNESCO, Paris.
33. Siddharthan, N.S., 1988. In-house R&D, imported technology, and firm size: lessons from Indian experience. The Developing Economies 3, 212-221.
34. Siddharthan, N.S., Agarwal, R.N., 1992. Determinants of R&D decisions: a cross-section study of Indian private corporate firms. Economic Innovation and New Technology 2, 103-110.
35. Singh, S., 1985. Multinational Corporations and the Indian Drug Industry. Criterion Publications, New Delhi.